In an amended 13D filing on Cormedix (NYSE: CRMD), hedge fund Elliott Associates disclosed a 8.6%, or 2,127,289 share, stake ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE